AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Maillot, F.
Right arrow Articles by Lee, P. J
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maillot, F.
Right arrow Articles by Lee, P. J
Agricola
Right arrow Articles by Maillot, F.
Right arrow Articles by Lee, P. J
American Journal of Clinical Nutrition, Vol. 88, No. 3, 700-705, September 2008
© 2008 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine1,2

François Maillot, Maggie Lilburn, Jenny Baudin, David W Morley and Philip J Lee

1 From the Charles Dent Metabolic Unit, The National Hospital for Neurology & Neurosurgery, London, United Kingdom (FM, ML, JB, and PJL), and the Environmental Change Research Centre, University College London, London, United Kingdom (DWM)

Background: Developmental delay in the offspring of women with phenylketonuria (PKU) can be prevented by maintaining maternal blood phenylalanine (Phe) within a target range (100–250 µmol/L).

Objective: We aimed to analyze outcomes in the offspring of women with PKU during pregnancy and to identify prognostic factors.

Design: Occipitofrontal circumference at birth (OFC-B); developmental scores [developmental quotient (DQ) and intelligence quotient (IQ)]at 1, 4, 8, and 14 y; and the time of starting a Phe-restricted diet (before or after conception) were collected. The influence of maternal Phe concentrations during pregnancy on offspring outcomes also was assessed.

Results: The study included 105 children born to 67 mothers with PKU. Mean (±SD) OFC-B z scores did not differ between the preconception and postconception diet groups (0.42 ± 1.24 and –0.96 ± 1.19, respectively). DQ at 1 y and IQ at 8 y were higher in offspring from the preconception diet group than in offspring from the postconception diet group [DQ: 107 ± 13.8 and 99.3 ± 13.3, respectively (P = 0.014); IQ: 110.6 ± 14.8 and 91.2 ± 23.9, respectively (P = 0.005)]. Maternal Phe concentrations correlated negatively with DQ and IQ scores, and variations (SD) in all maternal blood Phe correlated negatively with 4-, 8-, and 14-y IQ scores (r = –0.385, –0.433, and –0.712; P = 0.002, 0.008, and 0.031, respectively), even when concentrations were consistently within the target range.

Conclusions: The study suggests that women with PKU should start a Phe-restricted diet before conception. Maintenance of maternal blood Phe within the target range predicts good offspring outcomes, but variations even within that range should be avoided.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition